A new combination chemotherapy with Cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers

Internal Medicine

Volumn 38, Issue 11, 1999, Pages 844-848

  Yoshioka, Takashi ^a   Gamoh, Makio ^a   Shineha, Ryusaburo ^a   Ishibashi, Satoru ^a   Shibata, Hiroyuki ^a   Suzuki, Takao ^a   Murakawa, Yasuko ^a   Kato, Syunsuke ^a   Shimodaira, Hideki ^a   Kato, Satoshi ^a   Ishioka, Chikashi ^a   Kanamaru, Ryunosuke ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Antineoplastic agents; Cisplatin derivative; Drug effects; Squamous cell; Undifferentiated carcinoma

Indexed keywords

FLUOROURACIL; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ESOPHAGUS CARCINOMA; FEVER; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; NEPHROTOXICITY; PHLEBITIS; THROMBOCYTOPENIA;

EID: 0032707271     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.844     Document Type: Article

References (18)

1. Ajani AJ. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 21: 474-482, 1994.
2. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
3. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14: 156-163, 1996.
4. Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: Interim analysis of a phase II trial. J Clin Oncol 14: 829-837, 1996.
5. al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15: 277-284, 1997.
6. Urba SG, Turrisi III AT. Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus. Cancer 75: 435-439, 1995.
7. Leichman L, Berry BT. Experience with cisplatin in treatment regimens for esophageal cancer. Semin Oncol 18: 64-72, 1991.
8. Totani T, Aono K, Komura M. Synthesis of (Glycolato-o, o') diammine platinum (II) and its related complexes. Chemistry Letters, 1986: 429-432.
9. Taguchi T, Wakui A, Nabeya K, et al. A phase Il clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. Jpn J Cancer Chemother 19: 483-488, 1992.
10. Furukawa S, Yoshida T, Tukuda M, et al. Experimental study on combination chemotherapy with platinum compounds and 5-fluorouracil. Jpn J Cancer Chemother 16: 419-422, 1989.
11. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
12. Coonley CJ, Bains M, Hilaris B, Chapman R, Kelsen DP. Cisplatin and bleomycin in the treatment of esophageal carcinoma, a final report. Cancer 54: 2351-2355, 1984.
13. Engstrom PF, Lavin PT, Klaassen DJ. Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep 67: 713-715, 1983.
14. Dinwoodie WR, Bartolucci AA, Lyman GH, Velez-Garcia E, Martelo OJ, Sarma PR. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial. Cancer Treat Rep 70: 267-270, 1986.
15. Kies MS, Rosen ST, Tsang TK, et al. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 60: 2156-2160, 1987.
16. Ajani JA, Ryan B, Rich TA, et al. Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer 28A: 880-884, 1992.
17. Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol 22: 172-176, 1992.
18. Bleiberg H, Jacob JH, Bedenne L, Paillot B, De Besi P, Lacave A. Randomized phase II trial of 5-fluorouracil and cisplation versus cisplatin alone in advanced esophageal cancer (meeting abstract). Proc Ann Meet Am Soc Clin Oncol 10: A447, 1991.